Search

everythinglearnresearchcommunity

for

Search:↓

Older East and Southeast Asian men need less hair density for hair restoration satisfaction, and natural hairline features should guide surgery plans.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

Balding hair follicle cells are smaller, grow less well, and need more effort to culture than non-balding cells.

Hair from balding and non-balding areas regrows similarly on mice.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Balding scalps slow down hair growth.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Human hair growth is influenced by androgen hormones, and red deer mane follicles have similar hormone receptors.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Mast cells might contribute to hair loss by causing skin thickening.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Men can report their own balding patterns well enough for large health studies.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Minoxidil boosts enzymes that help hair growth.

Early balding men may have insulin resistance, but lifestyle changes can help.

Early balding at 40 increases prostate cancer risk.

Balding men had lower bone density, while balding women had higher hip bone density.

Early balding, especially frontal, increases prostate cancer risk; more research needed.